1-855-378-42281-855-378-4228
One of the out-patient treatment options for clients in Greers Ferry who are battling with opioid dependence and addiction is called opioid maintenance therapy. Some clinics and doctors are certified to dispense specific meds to opioid dependent clients, many of which are opioids themselves and are habit forming. With low doses however, the client doesn't experience high feelings but also does not experience acute cravings and isn't experiencing opioid withdrawal. Methadone is the first drug tried for this sole purpose, but there are alternative choices currently to select from.
Methadone is an opioid and can be taken at an out-patient clinic licensed to dispense the drug, that is taken daily in liquid or pill form. The price of the drug is approximately $150 monthly. Buprenorphine is also an opiate based med, and is a pill often taken one day on, one day off. But different from Methadone which is only be given in highly structured medical centers, Buprenorphine can be and is prescribed and administered in doctor's offices. The price monthly of buprenorphine is approximately three hundred dollars monthly for the generic of the medication. There is also a type of buprenorphine containing the drug naloxone, which is a drug which reverses the effects of opiates. A person taking this formulation, also known as Suboxone, would find it more difficult to feel high from opioids if they relapsed while taking the drug. It too is taken every day, and is priced around $450 monthly. Naltrexone is an additional drug taken in opioid maintenance therapy, but unlike the other medications aforementioned it is an opiate blocker and is not an opioid. There is an option to take this medication as a monthly shot, which is called Vivitrol. As an opioid blocker, it prevents someone from experience high feelings from opioids, and therefore lowers the risk associated with relapse. This daily shot costs in the range of $1000 to $1200 monthly.
For All Alcohol and Drug Rehab Facilities In Greers Ferry, Click Here.
